These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

511 related items for PubMed ID: 21454065

  • 1. Pediatric aspects of therapeutic drug monitoring of mycophenolic acid in renal transplantation.
    Tönshoff B, David-Neto E, Ettenger R, Filler G, van Gelder T, Goebel J, Kuypers DR, Tsai E, Vinks AA, Weber LT, Zimmerhackl LB.
    Transplant Rev (Orlando); 2011 Apr; 25(2):78-89. PubMed ID: 21454065
    [Abstract] [Full Text] [Related]

  • 2. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO, Ehlermann P, Koch A, Remppis A, Katus HA, Dengler TJ.
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [Abstract] [Full Text] [Related]

  • 3. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.
    Pawinski T, Durlik M, Szlaska I, Urbanowicz A, Majchrnak J, Gralak B.
    J Clin Pharm Ther; 2006 Feb; 31(1):27-34. PubMed ID: 16476117
    [Abstract] [Full Text] [Related]

  • 4. Validation of an abbreviated pharmacokinetic profile for the estimation of mycophenolic acid exposure in pediatric renal transplant recipients.
    Weber LT, Hoecker B, Armstrong VW, Oellerich M, Tönshoff B.
    Ther Drug Monit; 2006 Oct; 28(5):623-31. PubMed ID: 17038876
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic drug monitoring of mycophenolic acid: does it improve patient outcome?
    de Winter BC, Mathôt RA, van Hest RM, van Gelder T.
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):251-61. PubMed ID: 17428154
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of mycophenolic acid in kidney transplant patients receiving sirolimus versus cyclosporine.
    El Haggan W, Ficheux M, Debruyne D, Rognant N, Lobbedez T, Allard C, Coquerel A, Ryckelynck JP, Hurault de Ligny B.
    Transplant Proc; 2005 Mar; 37(2):864-6. PubMed ID: 15848558
    [Abstract] [Full Text] [Related]

  • 7. Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure.
    Tett SE, Saint-Marcoux F, Staatz CE, Brunet M, Vinks AA, Miura M, Marquet P, Kuypers DR, van Gelder T, Cattaneo D.
    Transplant Rev (Orlando); 2011 Apr; 25(2):47-57. PubMed ID: 21190834
    [Abstract] [Full Text] [Related]

  • 8. Limits to intensified mycophenolate mofetil dosing in kidney transplantation.
    Kiberd BA, Lawen J, Daley C.
    Ther Drug Monit; 2012 Dec; 34(6):736-8. PubMed ID: 23007746
    [Abstract] [Full Text] [Related]

  • 9. Mycophenolate pharmacokinetics in early period following lung or heart transplantation.
    Ensom MH, Partovi N, Decarie D, Ignaszewski AP, Fradet GJ, Levy RD.
    Ann Pharmacother; 2003 Dec; 37(12):1761-7. PubMed ID: 14632536
    [Abstract] [Full Text] [Related]

  • 10. Mycophenolic acid levels in pediatric heart transplant recipients receiving mycophenolate mofetil.
    Dipchand AI, Pietra B, McCrindle BW, Rosebrook-Bicknell HL, Boucek MM.
    J Heart Lung Transplant; 2001 Oct; 20(10):1035-43. PubMed ID: 11595558
    [Abstract] [Full Text] [Related]

  • 11. The pharmacokinetics of mycophenolate mofetil in Thai kidney transplant recipients.
    Jirasiritham S, Sumethkul V, Mavichak V, Na-Bangchang K.
    Transplant Proc; 2004 Sep; 36(7):2076-8. PubMed ID: 15518751
    [Abstract] [Full Text] [Related]

  • 12. Immunosuppressive drug monitoring of sirolimus and cyclosporine in pediatric patients.
    Oellerich M, Armstrong VW, Streit F, Weber L, Tönshoff B.
    Clin Biochem; 2004 Jun; 37(6):424-8. PubMed ID: 15183289
    [Abstract] [Full Text] [Related]

  • 13. Optimization of the dosing regimen of mycophenolate mofetil in pediatric liver transplant recipients.
    Barau C, Barrail-Tran A, Hemerziu B, Habes D, Taburet AM, Debray D, Furlan V.
    Liver Transpl; 2011 Oct; 17(10):1152-8. PubMed ID: 21695772
    [Abstract] [Full Text] [Related]

  • 14. A Retrospective Study on Mycophenolic Acid Drug Interactions: Effect of Prednisone, Sirolimus, and Tacrolimus With MPA.
    Alvarez-Elías AC, Yoo EC, Todorova EK, Singh RN, Filler G.
    Ther Drug Monit; 2017 Jun; 39(3):220-228. PubMed ID: 28437284
    [Abstract] [Full Text] [Related]

  • 15. AcylMPAG plasma concentrations and mycophenolic acid-related side effects in patients undergoing renal transplantation are not related to the UGT2B7-840G>A gene polymorphism.
    van Agteren M, Armstrong VW, van Schaik RH, de Fijter H, Hartmann A, Zeier M, Budde K, Kuypers D, Pisarski P, Le Meur Y, van der Werf M, Mamelok RD, Oellerich M, van Gelder T.
    Ther Drug Monit; 2008 Aug; 30(4):439-44. PubMed ID: 18641546
    [Abstract] [Full Text] [Related]

  • 16. Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation.
    Mardigyan V, Tchervenkov J, Metrakos P, Barkun J, Deschenes M, Cantarovich M.
    Clin Ther; 2005 Apr; 27(4):463-9. PubMed ID: 15922819
    [Abstract] [Full Text] [Related]

  • 17. Age-related variability of mycophenolate mofetil exposure in stable pediatric liver transplant recipients and influences of donor characteristics.
    Parant F, Rivet C, Boulieu R, Gagnieu MC, Dumortier J, Boillot O, Lachaux A.
    Ther Drug Monit; 2009 Dec; 31(6):727-33. PubMed ID: 19881404
    [Abstract] [Full Text] [Related]

  • 18. Monitoring mycophenolate in liver transplant recipients: toward a therapeutic range.
    Tredger JM, Brown NW, Adams J, Gonde CE, Dhawan A, Rela M, Heaton N.
    Liver Transpl; 2004 Apr; 10(4):492-502. PubMed ID: 15048791
    [Abstract] [Full Text] [Related]

  • 19. Long-term pharmacokinetics of mycophenolic acid in pediatric renal transplant recipients over 3 years posttransplant.
    Weber LT, Hoecker B, Armstrong VW, Oellerich M, Tönshoff B.
    Ther Drug Monit; 2008 Oct; 30(5):570-5. PubMed ID: 18758392
    [Abstract] [Full Text] [Related]

  • 20. Value of therapeutic drug monitoring of MMF therapy in pediatric transplantation.
    Filler G.
    Pediatr Transplant; 2006 Sep; 10(6):707-11. PubMed ID: 16911495
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.